
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long-term Efficacy and Tolerability of RPC4046 in an Open-Label Extension Trial of Patients With Eosinophilic Esophagitis
Evan S. Dellon, Margaret H. Collins, Marc E. Rothenberg, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 3, pp. 473-483.e17
Open Access | Times Cited: 76
Evan S. Dellon, Margaret H. Collins, Marc E. Rothenberg, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 3, pp. 473-483.e17
Open Access | Times Cited: 76
Showing 1-25 of 76 citing articles:
Type 2 chronic inflammatory diseases: targets, therapies and unmet needs
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 69
Pavel Kolkhir, Cezmi A. Akdiş, Mübeccel Akdiş, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 743-767
Closed Access | Times Cited: 69
Diagnosis and management of eosinophilic esophagitis in children: An update from the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
Jorge Amil Dias, Salvatore Oliva, Αλεξάνδρα Παπαδοπούλου, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024) Vol. 79, Iss. 2, pp. 394-437
Closed Access | Times Cited: 21
Jorge Amil Dias, Salvatore Oliva, Αλεξάνδρα Παπαδοπούλου, et al.
Journal of Pediatric Gastroenterology and Nutrition (2024) Vol. 79, Iss. 2, pp. 394-437
Closed Access | Times Cited: 21
Skin, gut, and lung barrier: Physiological interface and target of intervention for preventing and treating allergic diseases
Roberto Berni Canani, Marco Caminati, Laura R. Carucci, et al.
Allergy (2024) Vol. 79, Iss. 6, pp. 1485-1500
Open Access | Times Cited: 20
Roberto Berni Canani, Marco Caminati, Laura R. Carucci, et al.
Allergy (2024) Vol. 79, Iss. 6, pp. 1485-1500
Open Access | Times Cited: 20
ACG Clinical Guideline: Diagnosis and Management of Eosinophilic Esophagitis
Evan S. Dellon, Amanda B. Muir, David A. Katzka, et al.
The American Journal of Gastroenterology (2025) Vol. 120, Iss. 1, pp. 31-59
Closed Access | Times Cited: 12
Evan S. Dellon, Amanda B. Muir, David A. Katzka, et al.
The American Journal of Gastroenterology (2025) Vol. 120, Iss. 1, pp. 31-59
Closed Access | Times Cited: 12
Pathophysiology of Non-IgE-Mediated Food Allergy
Shouling Zhang, Scott H. Sicherer, M. Cecilia Berin, et al.
ImmunoTargets and Therapy (2021) Vol. Volume 10, pp. 431-446
Open Access | Times Cited: 61
Shouling Zhang, Scott H. Sicherer, M. Cecilia Berin, et al.
ImmunoTargets and Therapy (2021) Vol. Volume 10, pp. 431-446
Open Access | Times Cited: 61
Type 2 Inflammation in Eosinophilic Esophagitis: From Pathophysiology to Therapeutic Targets
Francesca Racca, Gaia Pellegatta, Giuseppe Cataldo, et al.
Frontiers in Physiology (2022) Vol. 12
Open Access | Times Cited: 54
Francesca Racca, Gaia Pellegatta, Giuseppe Cataldo, et al.
Frontiers in Physiology (2022) Vol. 12
Open Access | Times Cited: 54
Biologics in eosinophilic gastrointestinal diseases
Evan S. Dellon, Jonathan M. Spergel
Annals of Allergy Asthma & Immunology (2022) Vol. 130, Iss. 1, pp. 21-27
Open Access | Times Cited: 54
Evan S. Dellon, Jonathan M. Spergel
Annals of Allergy Asthma & Immunology (2022) Vol. 130, Iss. 1, pp. 21-27
Open Access | Times Cited: 54
S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
Zeitschrift für Gastroenterologie (2023) Vol. 61, Iss. 07, pp. 862-933
Open Access | Times Cited: 33
Zeitschrift für Gastroenterologie (2023) Vol. 61, Iss. 07, pp. 862-933
Open Access | Times Cited: 33
The evolving landscape of biologic therapies for atopic dermatitis: Present and future perspective
Eden David, Benjamin Ungar, Yael Renert‐Yuval, et al.
Clinical & Experimental Allergy (2023) Vol. 53, Iss. 2, pp. 156-172
Closed Access | Times Cited: 30
Eden David, Benjamin Ungar, Yael Renert‐Yuval, et al.
Clinical & Experimental Allergy (2023) Vol. 53, Iss. 2, pp. 156-172
Closed Access | Times Cited: 30
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring
Nicola de Bortoli, Pierfrancesco Visaggi, Roberto Penagini, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 7, pp. 1173-1184
Closed Access | Times Cited: 14
Nicola de Bortoli, Pierfrancesco Visaggi, Roberto Penagini, et al.
Digestive and Liver Disease (2024) Vol. 56, Iss. 7, pp. 1173-1184
Closed Access | Times Cited: 14
Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives
Grzegorz Kardas, Michał Panek, Piotr Kuna, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 38
Grzegorz Kardas, Michał Panek, Piotr Kuna, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 38
Disease Burden and Unmet Need in Eosinophilic Esophagitis
Albert J. Bredenoord, Kiran Patel, Alain Schoepfer, et al.
The American Journal of Gastroenterology (2022) Vol. 117, Iss. 8, pp. 1231-1241
Open Access | Times Cited: 33
Albert J. Bredenoord, Kiran Patel, Alain Schoepfer, et al.
The American Journal of Gastroenterology (2022) Vol. 117, Iss. 8, pp. 1231-1241
Open Access | Times Cited: 33
Eosinophilic esophagitis: Immune mechanisms and therapeutic targets
Dilawar Khokhar, Sahiti Marella, Gila Idelman, et al.
Clinical & Experimental Allergy (2022) Vol. 52, Iss. 10, pp. 1142-1156
Open Access | Times Cited: 32
Dilawar Khokhar, Sahiti Marella, Gila Idelman, et al.
Clinical & Experimental Allergy (2022) Vol. 52, Iss. 10, pp. 1142-1156
Open Access | Times Cited: 32
The role of biologics in pediatric food allergy and eosinophilic gastrointestinal disorders
Sayantani Sindher, Suzanne Barshow, Jyothi Tirumalasetty, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 3, pp. 595-606
Open Access | Times Cited: 22
Sayantani Sindher, Suzanne Barshow, Jyothi Tirumalasetty, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 151, Iss. 3, pp. 595-606
Open Access | Times Cited: 22
Medical treatment of eosinophilic esophagitis
James P. Franciosi, Morris Gordon, Vassiliki Sinopoulou, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Open Access | Times Cited: 21
James P. Franciosi, Morris Gordon, Vassiliki Sinopoulou, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Open Access | Times Cited: 21
The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs
Erminia Ridolo, Alessandro Barone, Martina Ottoni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1702-1702
Open Access | Times Cited: 7
Erminia Ridolo, Alessandro Barone, Martina Ottoni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1702-1702
Open Access | Times Cited: 7
The Dual Lens of Endoscopy and Histology in the Diagnosis and Management of Eosinophilic Gastrointestinal Disorders—A Comprehensive Review
Alberto Barchi, Edoardo Vespa, Sandro Passaretti, et al.
Diagnostics (2024) Vol. 14, Iss. 8, pp. 858-858
Open Access | Times Cited: 7
Alberto Barchi, Edoardo Vespa, Sandro Passaretti, et al.
Diagnostics (2024) Vol. 14, Iss. 8, pp. 858-858
Open Access | Times Cited: 7
Determination of a treatment response threshold for the Eosinophilic Esophagitis Endoscopic Reference Score
Cary C. Cotton, John T. Woosley, Susan E. Moist, et al.
Endoscopy (2021) Vol. 54, Iss. 07, pp. 635-643
Closed Access | Times Cited: 34
Cary C. Cotton, John T. Woosley, Susan E. Moist, et al.
Endoscopy (2021) Vol. 54, Iss. 07, pp. 635-643
Closed Access | Times Cited: 34
Biologics for allergic and immunologic diseases
Hideaki Morita, Kenji Matsumoto, Hirohisa Saito
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 4, pp. 766-777
Closed Access | Times Cited: 28
Hideaki Morita, Kenji Matsumoto, Hirohisa Saito
Journal of Allergy and Clinical Immunology (2022) Vol. 150, Iss. 4, pp. 766-777
Closed Access | Times Cited: 28
Epithelial cell‐expressed type II IL ‐4 receptor mediates eosinophilic esophagitis
Shmulik Avlas, Guy Shani, Natalie Rhone, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 464-476
Open Access | Times Cited: 27
Shmulik Avlas, Guy Shani, Natalie Rhone, et al.
Allergy (2022) Vol. 78, Iss. 2, pp. 464-476
Open Access | Times Cited: 27
Current and Novel Therapies for Eosinophilic Gastrointestinal Diseases
Giovanni Marasco, Pierfrancesco Visaggi, Mariagiulia Vassallo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15165-15165
Open Access | Times Cited: 16
Giovanni Marasco, Pierfrancesco Visaggi, Mariagiulia Vassallo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15165-15165
Open Access | Times Cited: 16
IL-13–induced STAT3-dependent signaling networks regulate esophageal epithelial proliferation in eosinophilic esophagitis
Sahiti Marella, Ankit Sharma, Varsha Ganesan, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 6, pp. 1550-1568
Closed Access | Times Cited: 14
Sahiti Marella, Ankit Sharma, Varsha Ganesan, et al.
Journal of Allergy and Clinical Immunology (2023) Vol. 152, Iss. 6, pp. 1550-1568
Closed Access | Times Cited: 14
Eosinophilic esophagitis in the era of biologics
Carlo Maria Rossi, Giovanni Santacroce, Marco Vincenzo Lenti, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 6, pp. 271-281
Open Access | Times Cited: 5
Carlo Maria Rossi, Giovanni Santacroce, Marco Vincenzo Lenti, et al.
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 6, pp. 271-281
Open Access | Times Cited: 5
Remission in Type 2 Inflammatory Diseases: Current Evidence, Unmet Needs, and Suggestions for Defining Remission in Chronic Rhinosinusitis with Nasal Polyps
Marco Caminati, Eugenio De Corso, Giancarlo Ottaviano, et al.
Current Allergy and Asthma Reports (2023) Vol. 24, Iss. 1, pp. 11-23
Open Access | Times Cited: 13
Marco Caminati, Eugenio De Corso, Giancarlo Ottaviano, et al.
Current Allergy and Asthma Reports (2023) Vol. 24, Iss. 1, pp. 11-23
Open Access | Times Cited: 13
Investigational anti IL-13 asthma treatments: a 2023 update
Maria Gabriella Matera, Josuel Ora, Luigino Calzetta, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 5, pp. 373-386
Closed Access | Times Cited: 12
Maria Gabriella Matera, Josuel Ora, Luigino Calzetta, et al.
Expert Opinion on Investigational Drugs (2023) Vol. 32, Iss. 5, pp. 373-386
Closed Access | Times Cited: 12